American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer.

PURPOSE To update brachytherapy recommendations for pretreatment evaluation, treatment, and dosimetric issues for thoracic brachytherapy for lung cancer. METHODS AND MATERIALS Members of the American Brachytherapy Society with expertise in thoracic brachytherapy updated recommendations for thoracic brachytherapy based on literature review and clinical experience. RESULTS The American Brachytherapy Society consensus guidelines recommend the use of endobronchial brachytherapy for disease palliation in patients with central obstructing lesions, particularly in patients who have previously received external beam radiotherapy. The use of interstitial implants after incomplete resection may improve outcomes and provide enhanced palliation. Early reports support the use of CT-guided intratumoral volume implants within clinical studies. The use of brachytherapy routinely after sublobar resection is not generally recommended, unless within the confines of a clinical trial or a registry. CONCLUSIONS American Brachytherapy Society recommendations for thoracic brachytherapy are provided. Practitioners are encouraged to follow these guidelines and to develop further clinical trials to examine this treatment modality to increase the evidence base for its use.

[1]  S. Kalnicki,et al.  Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[2]  R. Stephens,et al.  Treatment of endotracheal or endobronchial obstruction by non-small cell lung cancer: lack of patients in an MRC randomized trial leaves key questions unanswered. Medical Research Council Lung Cancer Working Party. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  J. Eichling,et al.  Radiation exposure to family and household members after prostate brachytherapy. , 2003, International journal of radiation oncology, biology, physics.

[4]  J. Port,et al.  Lung-conserving treatment of a pulmonary oligometastasis with a wedge resection and 131Cs brachytherapy. , 2013, Brachytherapy.

[5]  É. Vigneault,et al.  Retrospective study of 81 patients treated with brachytherapy for endobronchial primary tumor or metastasis. , 2010, Brachytherapy.

[6]  D. Silvern,et al.  Endobronchial brachytherapy provides excellent long-term control of recurrent granulation tissue after tracheal stenosis. , 2012, Brachytherapy.

[7]  N. Martini,et al.  Interstitial brachytherapy in cancer of the lung: a 20 year experience. , 1978, International journal of radiation oncology, biology, physics.

[8]  H. Ishikawa,et al.  Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma , 2012, Radiation oncology.

[9]  A. Chicheł,et al.  HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer--comparison of two different dose schedules. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  D. Heron,et al.  Dosimetric Evaluation of Radiation Exposure During I-125 Vicryl Mesh Implants: Implications for ACOSOG z4032 , 2007, Annals of Surgical Oncology.

[11]  M. Wollin,et al.  Iodine125 interstitial brachytherapy in the treatment of carcinoma of the lung , 1992, Journal of surgical oncology.

[12]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[13]  J. Blasko,et al.  Radiation safety parameters following prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[14]  K. Rosenzweig,et al.  Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline , 2011, Practical radiation oncology.

[15]  A. B. Brill,et al.  NCRP Report No. 116, Limitation of Exposure to Ionizing Radiation National Council on Radiation Protection, Bethesda, MD, 88 pages, $22.50 , 1994 .

[16]  K. Chao,et al.  Cesium-131 permanent seed brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff. , 2011, Brachytherapy.

[17]  D. Nori,et al.  Intraoperative brachytherapy using gelfoam radioactive plaque implants for resected stage iii non‐small cell lung cancer with positive margin: A pilot study , 1995, Journal of surgical oncology.

[18]  N. Martini,et al.  Value of perioperative brachytherapy in the management of non-oat cell carcinoma of the lung. , 1983, International journal of radiation oncology, biology, physics.

[19]  Dwight E Heron,et al.  Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial. , 2015, The Journal of thoracic and cardiovascular surgery.

[20]  R. Cormack,et al.  Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. , 2010, International journal of radiation oncology, biology, physics.

[21]  Moyed Miften,et al.  Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer , 2007, Physics in medicine and biology.

[22]  T. Mate,et al.  Extending the limits of lung cancer resection. , 1993, American journal of surgery.

[23]  R. Cormack,et al.  Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations. , 2007, International journal of radiation oncology, biology, physics.

[24]  M. Bains,et al.  Paraspinal tumors: techniques and results of brachytherapy. , 1991, International journal of radiation oncology, biology, physics.

[25]  L. Anderson,et al.  Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. , 1987, Radiology.

[26]  Joe Y. Chang,et al.  ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. , 2009, Journal of the American College of Radiology : JACR.

[27]  H. Hautmann,et al.  Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. , 1997, International journal of radiation oncology, biology, physics.

[28]  C. Armpilia,et al.  The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants. , 2003, International journal of radiation oncology, biology, physics.

[29]  Daqiang Sun,et al.  CT-guided 125I brachytherapy on pulmonary metastases after resection of colorectal cancer: A report of six cases , 2014, Oncology letters.

[30]  D. Heron,et al.  Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  R. Fischer,et al.  100 Prospective randomised trial on the role of HDR-brachytherapy in addition to external beam radiotherapy for central bronchial carcinoma , 1996 .

[32]  L. Manchikanti,et al.  Risk of whole body radiation exposure and protective measures in fluoroscopically guided interventional techniques: a prospective evaluation , 2003, BMC anesthesiology.

[33]  C. Sibata,et al.  Toward endobronchial Ir-192 high-dose-rate brachytherapy therapeutic optimization , 2007, Physics in medicine and biology.

[34]  S. Nag,et al.  Brachytherapy for carcinoma of the lung. , 2001, Oncology.

[35]  X. Li,et al.  Radiotherapy dose perturbation of metallic esophageal stents. , 2002, International journal of radiation oncology, biology, physics.

[36]  P. Christos,et al.  Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer. , 2015, Brachytherapy.

[37]  M. Rivard,et al.  Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. , 2003, The Annals of thoracic surgery.

[38]  J. López-Picazo,et al.  CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC). , 2008, Lung cancer.

[39]  J G H Sutherland,et al.  Metallic artifact mitigation and organ-constrained tissue assignment for Monte Carlo calculations of permanent implant lung brachytherapy. , 2013, Medical physics.

[40]  Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. , 2000 .

[41]  R. Landreneau,et al.  Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung. , 2008, Brachytherapy.

[42]  M. Fabrini,et al.  Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. , 2000, Lung cancer.

[43]  L. Anderson,et al.  Combined surgery, intraoperative brachytherapy, and postoperative external radiation in stage III non‐small cell lung cancer , 1985, Cancer.

[44]  D. Behera,et al.  Optimization of dose and fractionation of endobronchial brachytherapy with or without external radiation in the palliative management of non-small cell lung cancer: a prospective randomized study. , 2006, Journal of cancer research and therapeutics.

[45]  M. Gregorio,et al.  High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment. , 2013, Brachytherapy.

[46]  R. Dale,et al.  The clinical radiobiology of brachytherapy. , 1998, The British journal of radiology.

[47]  W. De Neve,et al.  Implementation, uptime, and safety of a pulsed dose rate afterloading machine. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[48]  R. Landreneau,et al.  Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. , 1998, Chest.

[49]  R. Landreneau,et al.  Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. , 2006, The Annals of thoracic surgery.

[50]  D. Heron,et al.  Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. , 2004, Brachytherapy.

[51]  N. Theodore,et al.  Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression. , 2001, International journal of radiation oncology, biology, physics.

[52]  J. Blasko,et al.  Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society. , 1993, International journal of radiation oncology, biology, physics.

[53]  C. Haie-meder,et al.  High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. , 2000, International journal of radiation oncology, biology, physics.

[54]  Impact of surface curvature on dose delivery in intraoperative high-dose-rate brachytherapy. , 2009, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[55]  J. Luketich,et al.  Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. , 2005, The Journal of thoracic and cardiovascular surgery.

[56]  R. Landreneau,et al.  Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer. , 2003, Surgery.

[57]  Junjie Wang,et al.  Dosimetric study of Cs-131, I-125, and Pd-103 seeds for permanent prostate brachytherapy. , 2009, Cancer biotherapy & radiopharmaceuticals.

[58]  J. Itami,et al.  Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies , 2001, Cancer.

[59]  A. Bezjak,et al.  International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control. , 2010, Clinical lung cancer.

[60]  R. Cormack,et al.  Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. , 2007, Brachytherapy.

[61]  R. Sur,et al.  Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone , 2004 .

[62]  J. Debus,et al.  Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results. , 2013, Tumori.

[63]  External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. , 2001 .

[64]  A. Meyer,et al.  HDR brachytherapy: an option for preventing nonmalignant obstruction in patients after lung transplantation , 2012, Strahlentherapie und Onkologie.

[65]  Y. Ko,et al.  Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG , 2012, Radiation oncology.

[66]  Lizhong Liu,et al.  On the use of C-arm fluoroscopy for treatment planning in high dose rate brachytherapy. , 2003, Medical physics.

[67]  C. Belka,et al.  Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors , 2013, Radiation Oncology.

[68]  P. Devlin,et al.  Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature. , 2009, Brachytherapy.

[69]  A. Chicheł,et al.  Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery. , 2013, Brachytherapy.

[70]  Ludovic Reveiz,et al.  Palliative endobronchial brachytherapy for non-small cell lung cancer. , 2012, The Cochrane database of systematic reviews.

[71]  M. Sato,et al.  Usefulness of mini-tracheostomy and torque controlled insertion of applicator in fractionated endobronchial brachytherapy. , 2006, The British journal of radiology.